Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Mind Medicine Mindmed Inc (MNMD)

Mind Medicine Mindmed Inc (MNMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 543,982
  • Shares Outstanding, K 75,553
  • Annual Sales, $ 0 K
  • Annual Income, $ -108,680 K
  • EBIT $ -114 M
  • EBITDA $ -113 M
  • 60-Month Beta 2.45
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.43

Options Overview Details

View History
  • Implied Volatility 89.23% ( +8.08%)
  • Historical Volatility 52.73%
  • IV Percentile 49%
  • IV Rank 32.94%
  • IV High 151.81% on 02/05/25
  • IV Low 58.49% on 10/01/24
  • Put/Call Vol Ratio 0.03
  • Today's Volume 1,418
  • Volume Avg (30-Day) 2,089
  • Put/Call OI Ratio 0.19
  • Today's Open Interest 50,929
  • Open Int (30-Day) 54,124

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate -0.37
  • Number of Estimates 3
  • High Estimate -0.35
  • Low Estimate -0.38
  • Prior Year -0.48
  • Growth Rate Est. (year over year) +22.92%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.34 +17.82%
on 06/23/25
8.19 -8.85%
on 06/10/25
-0.32 (-4.11%)
since 06/06/25
3-Month
4.70 +58.94%
on 04/09/25
8.21 -9.01%
on 05/20/25
+2.58 (+52.76%)
since 04/08/25
52-Week
4.70 +58.94%
on 04/09/25
10.44 -28.42%
on 02/14/25
+0.64 (+9.37%)
since 07/08/24

Most Recent Stories

More News
Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032

CMPS : 3.46 (+4.53%)
CYBN.NE : 10.3700 (-3.08%)
ATAI : 2.63 (-4.36%)
MMED.NE : 14.9000 (+9.48%)
SAGE : 9.16 (-0.11%)
MNMD : 7.47 (+3.75%)
CYBN : 7.63 (-3.05%)
Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032

EQNX::TICKER_START (NYSE:CYBN),(NEO:CYBN),(NASDAQ:CMPS),(NASDAQ:SAGE),(NASDAQ:MNMD),(NASDAQ:ATAI),(NEO:MMED) EQNX::TICKER_END

CMPS : 3.46 (+4.53%)
CYBN.NE : 10.3700 (-3.08%)
ATAI : 2.63 (-4.36%)
MMED.NE : 14.9000 (+9.48%)
SAGE : 9.16 (-0.11%)
MNMD : 7.47 (+3.75%)
CYBN : 7.63 (-3.05%)
Why Mind Medicine Gave Investors a Powerful Buzz in May

MNMD : 7.47 (+3.75%)
2 ‘Strong Buy’ Psychedelic Stocks to Scoop Up ASAP

Two psychedelic-focused stocks stand to benefit after the FDA designated psychedelics as a top review priority.

ATAI : 2.63 (-4.36%)
MNMD : 7.47 (+3.75%)
Why Mind Medicine Stock Vaulted More Than 8% Higher Today

NFLX : 1,275.31 (-1.11%)
MNMD : 7.47 (+3.75%)
Mind Medicine's Net Losses Swell In Q4, But Retail Finds At Least 3 Reasons To Stay Bullish

The psychedelics treatment developer reported a net loss of $34.7 million for the quarter ended Dec. 31, 2024, widening from a $23.8 million loss a year earlier.

CMPS : 3.46 (+4.53%)
MNMD : 7.47 (+3.75%)
Warren Buffett's State of the Market

Berkshire's cash hoard is approaching "Dr. Evil" levels.

AAPL : 210.01 (+0.03%)
BRK.A : 715,269.00 (-0.16%)
JNJ : 155.79 (+0.33%)
BRK.B : 477.47 (-0.12%)
BRK.TO : 35.53 (-0.14%)
SCHW : 91.95 (-0.70%)
MNMD : 7.47 (+3.75%)
TSM : 227.86 (-0.57%)
Why Mind Medicine Stock Is Skyrocketing Today

Mind Medicine (NASDAQ: MNMD) stock is seeing impressive gains Friday. The company's share price was up 16.9% as of 3:15 p.m. ET and had been up as much as 20.7% on the day earlier in the session.

MNMD : 7.47 (+3.75%)
Mind Medicine Getting An 'RFK Bump'? Retail Gets More Bullish As Stock Heads For Best Day In Over 10 Months

Kennedy has previously advocated for decriminalizing psychedelics for therapeutic use, citing his son’s positive experience with the hallucinogenic brew ayahuasca.

CMPS : 3.46 (+4.53%)
ATAI : 2.63 (-4.36%)
MNMD : 7.47 (+3.75%)
Mind Medicine Stock Rises As Evercore Projects 200% Upside On LSD Formulation: Retail Turns Bullish

The brokerage also pointed to potential large-scale expansion opportunities and emphasized the growing acceptance of psychedelics in future treatment paradigms.

XPH : 41.30 (+0.58%)
PSIL : 14.61 (-0.17%)
IWC : 132.33 (+0.72%)
MNMD : 7.47 (+3.75%)

Business Summary

Mind Medicine Inc. is a clinical-stage psychedelic medicine biotech company. It discovers, develops and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. Mind Medicine Inc. is based in New York, United States.

See More

Key Turning Points

3rd Resistance Point 7.80
2nd Resistance Point 7.65
1st Resistance Point 7.56
Last Price 7.47
1st Support Level 7.32
2nd Support Level 7.17
3rd Support Level 7.08

See More

52-Week High 10.44
Fibonacci 61.8% 8.24
Fibonacci 50% 7.57
Last Price 7.47
Fibonacci 38.2% 6.89
52-Week Low 4.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar